ESRRA and breast carcinoma: Chang et al. [25] reported similar challenges in correlating mRNA expression of family member ERRα with poor outcome in breast cancer clinical specimens, but successfully generated a reproducible measure of ERRα activity in vivo by monitoring the expression of receptor target genes.